FDA Orange Book · active-ingredient family
Clavulanate potassium; ticarcillin disodium
Clavulanate potassium; ticarcillin disodium is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:TIMENTIN IN PLASTIC CONTAINER · NDA 050658
2
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TIMENTIN IN PLASTIC CONTAINER | GLAXOSMITHKLINE | NDA 050658 | — | Dec 15, 1989 | |
| TIMENTIN×3 | GLAXOSMITHKLINE | NDA 050590 | — | Aug 18, 1987 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TIMENTIN | GLAXOSMITHKLINE | ANDA 062691 | — | Dec 19, 1986 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Clavulanate potassium; ticarcillin disodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
